PFBT
BPMC

Parkside Financial Bank & Trust’s Blueprint Medicines BPMC Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51
Closed -$6.54K – 2725
2025
Q2 		$6.54K Sell
51
-58
-53% -$6.02K ﹤0.01% 1622
2025
Q1 		$9.65K Buy
109
+25
+30% +$2.44K ﹤0.01% 1415
2024
Q4 		$7.33K Buy
+84
New +$7.69K ﹤0.01% 1368

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parkside Financial Bank & Trust's BPMC Position: Q3 2025 in Review

Parkside Financial Bank & Trust sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 51 shares — an estimated $6.54K sold.

Parkside Financial Bank & Trust first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $9.65K in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Parkside Financial Bank & Trust reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 51 Blueprint Medicines shares in Q3 2025, an estimated $6.54K.
  • Parkside Financial Bank & Trust first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Blueprint Medicines position peaked at $9.65K in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.